Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk
I
ndia’s leading doctors have warned of the dangers of an unregulated boom in weight loss injections, and emphasised they are not a magic pill to solve the country’s growing epidemic of diabetes and obesity.
Demand for appetite-suppressing drugs such as Mounjaro, Wegovy and Ozempic has surged since they were introduced into the Indian market this year.
In the eight months since it was approved for sale, Mounjaro – a jab that regulates blood sugar and suppresses appetite to help with diabetes and obesity – is now India’s highest-selling drug, overtaking antibiotics.
